BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 22528480)

  • 1. Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria.
    Royal W; Cherner M; Carr J; Habib AG; Akomolafe A; Abimiku A; Charurat M; Farley J; Oluyemisi A; Mamadu I; Johnson J; Ellis R; McCutchan JA; Grant I; Blattner WA
    J Neurovirol; 2012 Jun; 18(3):191-9. PubMed ID: 22528480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurocognitive impairment associated with predominantly early stage HIV infection in Abuja, Nigeria.
    Akolo C; Royal W; Cherner M; Okwuasaba K; Eyzaguirre L; Adebiyi R; Umlauf A; Hendrix T; Johnson J; Abimiku A; Blattner WA
    J Neurovirol; 2014 Aug; 20(4):380-7. PubMed ID: 24927825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurocognitive impairment in HIV-1 clade C- versus B-infected individuals in Southern Brazil.
    de Almeida SM; Ribeiro CE; de Pereira AP; Badiee J; Cherner M; Smith D; Maich I; Raboni SM; Rotta I; Barbosa FJ; Heaton RK; Umlauf A; Ellis RJ
    J Neurovirol; 2013 Dec; 19(6):550-6. PubMed ID: 24277437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between Cognition, Gender and Monocyte Activation among HIV Infected Individuals in Nigeria.
    Royal W; Cherner M; Burdo TH; Umlauf A; Letendre SL; Jumare J; Abimiku A; Alabi P; Alkali N; Bwala S; Okwuasaba K; Eyzaguirre LM; Akolo C; Guo M; Williams KC; Blattner WA
    PLoS One; 2016; 11(2):e0147182. PubMed ID: 26829391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of cigarette smoking with viral immune and cognitive function in human immunodeficiency virus-seropositive women.
    Wojna V; Robles L; Skolasky RL; Mayo R; Selnes O; de la Torre T; Maldonado E; Nath A; Meléndez LM; Lasalde-Dominicci J
    J Neurovirol; 2007 Dec; 13(6):561-8. PubMed ID: 18097887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction Effects between HIV and Aging on Selective Neurocognitive Impairment.
    Ding Y; Lin H; Shen W; Wu Q; Gao M; He N
    J Neuroimmune Pharmacol; 2017 Dec; 12(4):661-669. PubMed ID: 28470583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity of the International HIV Dementia Scale in South Africa.
    Joska JA; Westgarth-Taylor J; Hoare J; Thomas KG; Paul R; Myer L; Stein DJ
    AIDS Patient Care STDS; 2011 Feb; 25(2):95-101. PubMed ID: 21214343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive Function Among Antiretroviral Treatment-Naive Individuals Infected With Human Immunodeficiency Virus Type 1 Subtype G Versus CRF02_AG in Nigeria.
    Jumare J; Ndembi N; El-Kamary SS; Magder L; Hungerford L; Burdo T; Eyzaguirre LM; Dakum P; Umlauf A; Cherner M; Abimiku A; Charurat M; Blattner WA; Royal W
    Clin Infect Dis; 2018 Apr; 66(9):1448-1453. PubMed ID: 29182762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 effects on neuropsychological performance in a resource-limited country, Zambia.
    Holguin A; Banda M; Willen EJ; Malama C; Chiyenu KO; Mudenda VC; Wood C
    AIDS Behav; 2011 Nov; 15(8):1895-901. PubMed ID: 21744118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurocognitive impairment among HIV-positive individuals in Botswana: a pilot study.
    Lawler K; Mosepele M; Ratcliffe S; Seloilwe E; Steele K; Nthobatsang R; Steenhoff A
    J Int AIDS Soc; 2010 Apr; 13():15. PubMed ID: 20406460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normative scores for select neuropsychological battery tests for the detection of HIV-associated neurocognitive disorder amongst Nigerians.
    Nweke M; Mshunqane N; Govender N; Akinpelu AO; Ogunniyi A
    Niger Postgrad Med J; 2022; 29(3):262-267. PubMed ID: 35900464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlations between computerized battery testing and a memory questionnaire for identification of neurocognitive impairment in HIV type 1-infected subjects on stable antiretroviral therapy.
    Garvey LJ; Yerrakalva D; Winston A
    AIDS Res Hum Retroviruses; 2009 Aug; 25(8):765-9. PubMed ID: 19678764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease.
    Letendre SL; Cherner M; Ellis RJ; Marquie-Beck J; Gragg B; Marcotte T; Heaton RK; McCutchan JA; Grant I;
    AIDS; 2005 Oct; 19 Suppl 3():S72-8. PubMed ID: 16251831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depression and diagnosis of neurocognitive impairment in HIV-positive patients.
    Pinheiro CA; Souza LD; Motta JV; Kelbert EF; Souza MS; Martins CS; Coelho FM; Pinheiro KA; Pinheiro RT
    Braz J Med Biol Res; 2016 Sep; 49(10):e5344. PubMed ID: 27626305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral biomarkers do not correlate with cognitive impairment in highly active antiretroviral therapy-treated subjects with human immunodeficiency virus type 1 infection.
    Sun B; Abadjian L; Rempel H; Calosing C; Rothlind J; Pulliam L
    J Neurovirol; 2010 Mar; 16(2):115-24. PubMed ID: 20307252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological deficits in human immunodeficiency virus type 1 clade C-seropositive adults from South India.
    Gupta JD; Satishchandra P; Gopukumar K; Wilkie F; Waldrop-Valverde D; Ellis R; Ownby R; Subbakrishna DK; Desai A; Kamat A; Ravi V; Rao BS; Satish KS; Kumar M
    J Neurovirol; 2007 Jun; 13(3):195-202. PubMed ID: 17613709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurologic manifestations of human immunodeficiency virus-2: dementia, myelopathy, and neuropathy in West Africa.
    Choi Y; Townend J; Vincent T; Zaidi I; Sarge-Njie R; Jaye A; Clifford DB
    J Neurovirol; 2011 Apr; 17(2):166-75. PubMed ID: 21424866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurocognitive functioning in acute or early HIV infection.
    Moore DJ; Letendre SL; Morris S; Umlauf A; Deutsch R; Smith DM; Little S; Rooney A; Franklin DR; Gouaux B; Leblanc S; Rosario D; Fennema-Notestine C; Heaton RK; Ellis RJ; Atkinson JH; Grant I;
    J Neurovirol; 2011 Feb; 17(1):50-7. PubMed ID: 21165782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving Detection of HIV-Associated Cognitive Impairment: Comparison of the International HIV Dementia Scale and a Brief Screening Battery.
    de Almeida SM; Kamat R; Cherner M; Umlauf A; Ribeiro CE; de Pereira AP; Franklin D; Heaton RK; Ellis RJ
    J Acquir Immune Defic Syndr; 2017 Mar; 74(3):332-338. PubMed ID: 27828876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of an abbreviated test battery for detection of HIV-associated neurocognitive impairment in an early-managed HIV-infected cohort.
    Moore DJ; Roediger MJ; Eberly LE; Blackstone K; Hale B; Weintrob A; Ganesan A; Agan BK; Letendre SL; Crum-Cianflone NF
    PLoS One; 2012; 7(11):e47310. PubMed ID: 23144815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.